These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1548 related articles for article (PubMed ID: 15338272)

  • 1. Stages in the development of Parkinson's disease-related pathology.
    Braak H; Ghebremedhin E; Rüb U; Bratzke H; Del Tredici K
    Cell Tissue Res; 2004 Oct; 318(1):121-34. PubMed ID: 15338272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathophysiology of sporadic Parkinson's disease].
    Braak H; Del Tredici K
    Fortschr Neurol Psychiatr; 2010 Mar; 78 Suppl 1():S2-4. PubMed ID: 20195936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered.
    Braak H; Bohl JR; Müller CM; Rüb U; de Vos RA; Del Tredici K
    Mov Disord; 2006 Dec; 21(12):2042-51. PubMed ID: 17078043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages).
    Braak H; Del Tredici K; Bratzke H; Hamm-Clement J; Sandmann-Keil D; Rüb U
    J Neurol; 2002 Oct; 249 Suppl 3():III/1-5. PubMed ID: 12528692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology associated with sporadic Parkinson's disease--where does it end?
    Braak H; Müller CM; Rüb U; Ackermann H; Bratzke H; de Vos RA; Del Tredici K
    J Neural Transm Suppl; 2006; (70):89-97. PubMed ID: 17017514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nigral and extranigral pathology in Parkinson's disease.
    Braak H; Braak E; Yilmazer D; Schultz C; de Vos RA; Jansen EN
    J Neural Transm Suppl; 1995; 46():15-31. PubMed ID: 8821039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology.
    Braak H; de Vos RA; Bohl J; Del Tredici K
    Neurosci Lett; 2006 Mar; 396(1):67-72. PubMed ID: 16330147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen.
    Braak H; Rüb U; Gai WP; Del Tredici K
    J Neural Transm (Vienna); 2003 May; 110(5):517-36. PubMed ID: 12721813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical reappraisal of current staging of Lewy-related pathology in human brain.
    Jellinger KA
    Acta Neuropathol; 2008 Jul; 116(1):1-16. PubMed ID: 18592254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic Parkinson's disease: a review of clinical types and pathology.
    Olasode BJ
    Niger J Med; 2001; 10(3):116-20. PubMed ID: 11806009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Premotor diagnosis of Parkinson's disease].
    Morales-Briceño H; Cervantes-Arriaga A; Rodríguez-Violante M
    Gac Med Mex; 2011; 147(1):22-32. PubMed ID: 21412393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olfactory pathogenesis of idiopathic Parkinson disease revisited.
    Lerner A; Bagic A
    Mov Disord; 2008 Jun; 23(8):1076-84. PubMed ID: 18442121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presymptomatic detection of Parkinson's disease.
    Jenner P
    J Neural Transm Suppl; 1993; 40():23-36. PubMed ID: 8294898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the alpha-synuclein gene.
    Yamaguchi K; Cochran EJ; Murrell JR; Polymeropoulos MH; Shannon KM; Crowther RA; Goedert M; Ghetti B
    Acta Neuropathol; 2005 Sep; 110(3):298-305. PubMed ID: 15981014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversy: is Parkinson's disease a single disease entity? Yes.
    Takahashi H; Wakabayashi K
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S31-7. PubMed ID: 15885626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathoanatomy of Parkinson's disease.
    Braak H; Braak E
    J Neurol; 2000 Apr; 247 Suppl 2():II3-10. PubMed ID: 10991663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease: clinical aspects.
    Klockgether T
    Cell Tissue Res; 2004 Oct; 318(1):115-20. PubMed ID: 15365814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease: the dual hit theory revisited.
    Hawkes CH; Del Tredici K; Braak H
    Ann N Y Acad Sci; 2009 Jul; 1170():615-22. PubMed ID: 19686202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The second brain and Parkinson's disease.
    Lebouvier T; Chaumette T; Paillusson S; Duyckaerts C; Bruley des Varannes S; Neunlist M; Derkinderen P
    Eur J Neurosci; 2009 Sep; 30(5):735-41. PubMed ID: 19712093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 78.